These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3131554)

  • 41. Coronary thrombolysis--overwhelming evidence for mortality reduction in acute myocardial infarction.
    Cairns JA
    Can J Cardiol; 1988; 4(5):211-3. PubMed ID: 3136899
    [No Abstract]   [Full Text] [Related]  

  • 42. [Fast helicopter ambulance transfer of patients with acute myocardial infarction and thrombolytic therapy (rTPA)].
    De Trana L; Latronico S; Mileti L
    Minerva Anestesiol; 1991 Dec; 57(12):1659-60. PubMed ID: 1795806
    [No Abstract]   [Full Text] [Related]  

  • 43. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 44. [New specifics registered in Austria].
    Wien Klin Wochenschr; 1987 Oct; 99(19):694-700. PubMed ID: 3120421
    [No Abstract]   [Full Text] [Related]  

  • 45. New thrombolytic drugs in acute myocardial infarction: theoretical and practical considerations.
    Verstraete M
    Circulation; 1987 Aug; 76(2 Pt 2):II31-8. PubMed ID: 3111745
    [No Abstract]   [Full Text] [Related]  

  • 46. Primary angioplasty or thrombolysis for acute myocardial infarction?
    Massel D
    Lancet; 2003 Mar; 361(9361):967; author reply 967-8. PubMed ID: 12648991
    [No Abstract]   [Full Text] [Related]  

  • 47. Tenecteplase: single-bolus thrombolytic therapy for acute myocardial infarction.
    McGahan L
    Issues Emerg Health Technol; 2001 Jan; (13):1-6. PubMed ID: 11902221
    [No Abstract]   [Full Text] [Related]  

  • 48. Providers uncertain about TPA use.
    Wagner M
    Mod Healthc; 1988 Jan; 18(3):40. PubMed ID: 10317995
    [No Abstract]   [Full Text] [Related]  

  • 49. Cost effectiveness of tissue plasminogen activator.
    Lee TH
    N Engl J Med; 1995 May; 332(21):1443-4. PubMed ID: 7723804
    [No Abstract]   [Full Text] [Related]  

  • 50. [Tissue plasminogen activator reduces the spread of infarction].
    Bergfeldt L
    Lakartidningen; 1989 Dec; 86(52):4598. PubMed ID: 2514321
    [No Abstract]   [Full Text] [Related]  

  • 51. From the Health Care Financing Administration.
    Roper WL
    JAMA; 1988 Jun; 259(24):3530. PubMed ID: 3131554
    [No Abstract]   [Full Text] [Related]  

  • 52. [Tissue-type plasminogen activator and pro-urokinase--new fibrinolytic agents in the treatment of myocardial infarction].
    Czyrski J
    Wiad Lek; 1989 Apr; 42(7):450-2. PubMed ID: 2516932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue plasminogen activator: an update.
    Myears DW; Ludbrook PA
    Compr Ther; 1989 Apr; 15(4):3-9. PubMed ID: 2495884
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.